HAYWARD, Calif., June 13 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN - News) announced the appointment of Kevan Clemens, Ph.D., to its Board of Directors. Dr. Clemens will serve as chairman of the Board's Strategic Advisory Committee and will serve as a member of the Compensation and Corporate Governance and Nominating Committees.
